Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 3 | 3 | 6 | 16 | 10 | 1 | 1 | 1 | 2 | 3 | | 4 |
% Growth | NA | -8.2% | 133.1% | 166.3% | -38.0% | -89.4% | -23.7% | 1.7% | 158.6% | 41.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | (0) | 0 | (1) | (1) | (1) | (1) | (1) | (2) | (2) | | (2) |
Gross Profit | 3 | 2 | 6 | 15 | 9 | (0) | (0) | (0) | 0 | 1 | | 1 |
% Revenue | 100.0% | 82.8% | 100.0% | 94.0% | 86.5% | -26.4% | -26.0% | -58.0% | 1.2% | 22.0% | | 37.4% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | (1) | (3) | (5) | (5) | (1) | (0) | (0) | (1) | (2) | | (1) |
General and Admin | (2) | (1) | (1) | (3) | (13) | (2) | (2) | (2) | (2) | (3) | | (2) |
Other Inc / (Exp) | (0) | (0) | (2) | (0) | (7) | (1) | (0) | (0) | (2) | (1) | | (2) |
Total Operating Exp | (2) | (2) | (6) | (8) | (26) | (4) | (2) | (3) | (4) | (6) | | (5) |
| | | | | | | | | | | | |
Operating Income | 1 | 0 | 0 | 7 | (17) | (4) | (2) | (3) | (4) | (5) | | (4) |
% Revenue | 40.2% | 18.8% | 1.1% | 46.2% | -168.4% | -410.7% | -275.6% | -396.1% | -198.6% | -168.2% | | -104.0% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | (0) | 0 | 0 | (0) | (0) | (0) | (0) | (0) | | (0) |
Pre-tax Income | 1 | 1 | 0 | 8 | (17) | (4) | (2) | (3) | (4) | (5) | | (4) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | (0) | (1) | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (0) | (1) | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Company | 1 | 1 | 0 | 7 | (17) | (5) | (2) | (3) | (4) | (5) | | (4) |
% Margin | 40.0% | 20.2% | 0.3% | 41.9% | -166.3% | -488.6% | -292.9% | -412.6% | -199.6% | -180.8% | | -109.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 1 | 1 | 0 | 7 | (15) | (4) | (2) | (3) | (4) | (5) | | (4) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | (0) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 1 | 1 | 0 | 7 | (15) | (3) | (2) | (3) | (4) | (5) | | (4) |
% Margin | 40.0% | 19.3% | 0.3% | 45.3% | -147.2% | -271.4% | -291.4% | -405.3% | -199.6% | -180.8% | | -109.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.01 | 0.00 | 0.10 | (0.20) | (0.04) | (0.02) | (0.02) | (0.02) | (0.02) | | (0.01) |
Diluted EPS (Continuing Ops) | 0.00 | 0.01 | 0.00 | 0.09 | (0.20) | (0.04) | (0.02) | (0.02) | (0.02) | (0.02) | | (0.01) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 43.75 | 53.12 | 72.13 | 74.82 | 80.53 | 95.68 | 174.33 | 260.48 | 326.12 | | 483.50 |
WA Diluted Shares Out. | 0.00 | 43.75 | 55.79 | 77.65 | 74.82 | 80.53 | 95.68 | 174.33 | 260.48 | 326.12 | | 483.50 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 1 | 1 | 0 | 8 | (17) | (4) | (2) | (3) | (4) | (5) | | (4) |
Addback: Net Interest Expense | (0) | (0) | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | 1 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | 1 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 6 | 1 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 1 | 1 | 2 | 8 | (10) | (3) | (2) | (3) | (3) | (4) | | (2) |
% Margin | 41.3% | 26.9% | 34.7% | 48.5% | -99.8% | -299.8% | -265.5% | -382.8% | -125.7% | -121.2% | | -60.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 1 | 0 | 2 | 7 | (10) | (3) | (2) | (3) | (3) | (4) | | (3) |
% Margin | 41.0% | 18.8% | 33.2% | 46.2% | -103.8% | -312.9% | -275.6% | -396.1% | -147.4% | -141.2% | | -81.6% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 1 | 1 | 0 | 7 | (17) | (5) | (2) | (3) | (4) | (5) | | (4) |
Addback: Unusual Items | 0 | 0 | 2 | 0 | 6 | 1 | 0 | 0 | 1 | 1 | | 1 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | (1) | 0 | (2) | (0) | 0 | 0 | (0) | (0) | | (0) |
Adjusted Net Income | 1 | 1 | 1 | 7 | (12) | (4) | (2) | (3) | (3) | (5) | | (3) |
% Margin | 40.0% | 20.2% | 24.1% | 41.9% | -118.6% | -416.2% | -292.9% | -412.6% | -161.7% | -160.9% | | -93.0% |